{"result": "(\"entity\"<|>SARCOMA<|>EVENT<|>Sarcoma is a type of disease characterized by various symptoms and localizations in the human body.)\n##\n(\"entity\"<|>MITOXANTRONE<|>ORGANIZATION<|>Mitoxantrone is a topoisomerase inhibitor used to treat Sarcoma, with various side effects including abdominal pain and agranulocytosis.)\n##\n(\"entity\"<|>VINCRISTINE<|>ORGANIZATION<|>Vincristine is a vinca alkaloid that treats Sarcoma, associated with side effects like abdominal cramps and alopecia.)\n##\n(\"entity\"<|>DACTINOMYCIN<|>ORGANIZATION<|>Dactinomycin is a compound used to treat Sarcoma, with side effects such as abdominal pain and agranulocytosis.)\n##\n(\"entity\"<|>THIOTEPA<|>ORGANIZATION<|>Thiotepa is an alkylating agent that treats Sarcoma, with side effects including abdominal pain and agranulocytosis.)\n##\n(\"entity\"<|>ETOPOSIDE<|>ORGANIZATION<|>Etoposide is a topoisomerase inhibitor that treats Sarcoma, with side effects like abdominal pain and agranulocytosis.)\n##\n(\"entity\"<|>DOXORUBICIN<|>ORGANIZATION<|>Doxorubicin is a topoisomerase inhibitor used to treat Sarcoma, associated with side effects such as abdominal distension and agranulocytosis.)\n##\n(\"entity\"<|>EPIRUBICIN<|>ORGANIZATION<|>Epirubicin is a topoisomerase inhibitor that treats Sarcoma, with side effects including abdominal distension and agranulocytosis.)\n##\n(\"entity\"<|>DACARBAZINE<|>ORGANIZATION<|>Dacarbazine is an alkylating agent used to treat Sarcoma, with unspecified side effects.)\n##\n(\"entity\"<|>ABDOMEN<|>GEO<|>The abdomen is a part of the human body where symptoms of Sarcoma can manifest.)\n##\n(\"entity\"<|>LYMPH NODE<|>GEO<|>Lymph nodes are areas in the human body where Sarcoma can localize.)\n##\n(\"entity\"<|>TENDON<|>GEO<|>Tendons are parts of the human body where Sarcoma can localize.)\n##\n(\"entity\"<|>TESTIS<|>GEO<|>The testis is a part of the human body where Sarcoma can localize.)\n##\n(\"entity\"<|>EMBRYO<|>GEO<|>The embryo is a stage in human development where Sarcoma can localize.)\n##\n(\"entity\"<|>STERNUM<|>GEO<|>The sternum is a part of the human body where Sarcoma can localize.)\n##\n(\"entity\"<|>PLEURA<|>GEO<|>The pleura is a part of the human body where Sarcoma can localize.)\n##\n(\"entity\"<|>LEG<|>GEO<|>The leg is a part of the human body where Sarcoma can localize.)\n##\n(\"entity\"<|>UTERUS<|>GEO<|>The uterus is a part of the human body where Sarcoma can localize.)\n##\n(\"entity\"<|>SEMINAL VESICLE<|>GEO<|>The seminal vesicle is a part of the human body where Sarcoma can localize.)\n##\n(\"relationship\"<|>SARCOMA<|>MITOXANTRONE<|>Mitoxantrone is used to treat Sarcoma, indicating a direct therapeutic relationship<|>9)\n##\n(\"relationship\"<|>SARCOMA<|>VINCRISTINE<|>Vincristine is used to treat Sarcoma, indicating a direct therapeutic relationship<|>9)\n##\n(\"relationship\"<|>SARCOMA<|>DACTINOMYCIN<|>Dactinomycin is used to treat Sarcoma, indicating a direct therapeutic relationship<|>9)\n##\n(\"relationship\"<|>SARCOMA<|>THIOTEPA<|>Thiotepa is used to treat Sarcoma, indicating a direct therapeutic relationship<|>9)\n##\n(\"relationship\"<|>SARCOMA<|>ETOPOSIDE<|>Etoposide is used to treat Sarcoma, indicating a direct therapeutic relationship<|>9)\n##\n(\"relationship\"<|>SARCOMA<|>DOXORUBICIN<|>Doxorubicin is used to treat Sarcoma, indicating a direct therapeutic relationship<|>9)\n##\n(\"relationship\"<|>SARCOMA<|>EPIRUBICIN<|>Epirubicin is used to treat Sarcoma, indicating a direct therapeutic relationship<|>9)\n##\n(\"relationship\"<|>SARCOMA<|>DACARBAZINE<|>Dacarbazine is used to treat Sarcoma, indicating a direct therapeutic relationship<|>9)\n##\n(\"relationship\"<|>SARCOMA<|>ABDOMEN<|>Sarcoma presents symptoms in the abdomen, indicating a relationship between the disease and the body part<|>7)\n##\n(\"relationship\"<|>SARCOMA<|>LYMPH NODE<|>Sarcoma can localize in lymph nodes, indicating a relationship between the disease and the body part<|>7)\n##\n(\"relationship\"<|>SARCOMA<|>TENDON<|>Sarcoma can localize in tendons, indicating a relationship between the disease and the body part<|>7)\n##\n(\"relationship\"<|>SARCOMA<|>TESTIS<|>Sarcoma can localize in the testis, indicating a relationship between the disease and the body part<|>7)\n##\n(\"relationship\"<|>SARCOMA<|>EMBRYO<|>Sarcoma can localize in the embryo, indicating a relationship between the disease and the body part<|>7)\n##\n(\"relationship\"<|>SARCOMA<|>STERNUM<|>Sarcoma can localize in the sternum, indicating a relationship between the disease and the body part<|>7)\n##\n(\"relationship\"<|>SARCOMA<|>PLEURA<|>Sarcoma can localize in the pleura, indicating a relationship between the disease and the body part<|>7)\n##\n(\"relationship\"<|>SARCOMA<|>LEG<|>Sarcoma can localize in the leg, indicating a relationship between the disease and the body part<|>7)\n##\n(\"relationship\"<|>SARCOMA<|>UTERUS<|>Sarcoma can localize in the uterus, indicating a relationship between the disease and the body part<|>7)\n##\n(\"relationship\"<|>SARCOMA<|>SEMINAL VESICLE<|>Sarcoma can localize in the seminal vesicle, indicating a relationship between the disease and the body part<|>7)\n<|COMPLETE|>", "input": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: [Sarcoma] is the name of a kind of disease.\n[Sarcoma] presents the symptom [Abdomen, Acute].\n[Sarcoma] presents the symptom [Anorexia].\n[Sarcoma] presents the symptom [Anoxia].\n[Sarcoma] presents the symptom [Back Pain].\n[Sarcoma] presents the symptom [Body Weight].\n[Sarcoma] presents the symptom [Cachexia].\n[Sarcoma] presents the symptom [Chest Pain].\n[Sarcoma] presents the symptom [Cough].\n[Sarcoma] presents the symptom [Diplopia].\n[Sarcoma] presents the symptom [Dyspnea].\n[Sarcoma] localizes at the [Appendage] of human body.\n[Sarcoma] localizes at the [Lymph Node] of human body.\n[Sarcoma] localizes at the [Tendon] of human body.\n[Sarcoma] localizes at the [Testis] of human body.\n[Sarcoma] localizes at the [Embryo] of human body.\n[Sarcoma] localizes at the [Sternum] of human body.\n[Sarcoma] localizes at the [Pleura] of human body.\n[Sarcoma] localizes at the [Leg] of human body.\n[Sarcoma] localizes at the [Uterus] of human body.\n[Sarcoma] localizes at the [Seminal Vesicle] of human body.\n\nThe following content describes information about compounds that can palliate or treat the disease named Sarcoma.The format of each compound's information is as follows:\nCompound name: ***\nPharmacologic class: ***\nEffect on Sarcoma: Palliate or Treat\nSide effect: ***\nThese respectively represent the name of the compound, the pharmacologic class it belongs to, its positive effect on the disease named Sarcoma (palliates or treats) and its side effects.\n\nCompound name: Mitoxantrone\nPharmacologic class: Topoisomerase Inhibitors\nEffect on Sarcoma: Treat\nSide effect: Abdominal pain, Agranulocytosis, Alopecia, Amenorrhoea, Anaphylactic shock, Anaemia, Anorexia, Anxiety, Arrhythmia, Arthralgia\n\nCompound name: Vincristine\nPharmacologic class: Vinca Alkaloids\nEffect on Sarcoma: Treat\nSide effect: Acute abdomen, Abdominal cramps, Abdominal pain, Adrenal disorder, Alopecia, Anaphylactic shock, Anaemia, Anorexia, Asthenia, Ataxia\n\nCompound name: Dactinomycin\nPharmacologic class: None\nEffect on Sarcoma: Treat\nSide effect: Abdominal pain, Agranulocytosis, Alopecia, Anaemia, Aplastic anaemia, Anorexia, Ascites, Asthenia, Coagulopathy, Cheilitis\n\nCompound name: Thiotepa\nPharmacologic class: Alkylating Activity\nEffect on Sarcoma: Treat\nSide effect: Abdominal pain, Agranulocytosis, Alopecia, Amenorrhoea, Anaemia, Anorexia, Anxiety, Arrhythmia, Arthralgia, Asthenia\n\nCompound name: Etoposide\nPharmacologic class: Topoisomerase Inhibitors\nEffect on Sarcoma: Treat\nSide effect: Abdominal pain, Agranulocytosis, Alopecia, Anaphylactic shock, Anaemia, Anorexia, Apnoea, Ascites, Asthenia, Back pain\n\nCompound name: Doxorubicin\nPharmacologic class: Topoisomerase Inhibitors\nEffect on Sarcoma: Treat\nSide effect: Abdominal distension, Abdominal pain, Abscess, Lactic acidosis, Agranulocytosis, Albuminuria, Alopecia, Amblyopia, Amenorrhoea, Anaphylactic shock\n\nCompound name: Epirubicin\nPharmacologic class: Topoisomerase Inhibitors\nEffect on Sarcoma: Treat\nSide effect: Abdominal distension, Abdominal pain, Abscess, Lactic acidosis, Agranulocytosis, Albuminuria, Alopecia, Amblyopia, Amenorrhoea, Anaphylactic shock\n\nCompound name: Dacarbazine\nPharmacologic class: Alkylating Activity\nEffect on Sarcoma: Treat\nSide effect:\n######################\nOutput:", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": null}